25.5
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Fur…
Diabetes can be initially identified based on symptoms.
Hyperglycemic patients may present common symptoms, including polyuria, polydipsia, fatigue, and weight loss.
Diabetes is confirmed by blood glucose tests and oral glucose tolerance tests.
On fasting, a healthy person will have a plasma glucose concentration ＜100 mg/dL, while patients with hyperglycemia will have a plasma glucose concentration ≥ 126 mg/dL, or an oral glucose tolerance test showing plasma glucose levels ≥ 200 mg/dL.
They will have A1c levels ≥ 6.5%, indicating average blood sugar levels over 3 consecutive months.
Diabetes, when untreated, can lead to severe metabolic disturbances such as diabetic ketoacidosis and a hyperglycemic hyperosmolar state.
It can also lead to chronic end-organ effects, such as retinopathy, nephropathy, neuropathy, myocardial infarction, and stroke.
View the full transcript and gain access to JoVE Core videos
Q1: What are the early warning signs that someone might have diabetes?
Common early symptoms of diabetes include polyuria (excessive urination), polydipsia (excessive thirst), fatigue, and unexplained weight loss. These symptoms may develop over several weeks in newly diagnosed patients. If you experience multiple symptoms simultaneously, medical evaluation through blood glucose testing is recommended for confirmation.
Q2: How is diabetes diagnosed using blood glucose tests?
Diabetes is confirmed through specific blood glucose thresholds. A fasting plasma glucose of 126 mg/dL or higher, or an oral glucose tolerance test showing plasma glucose levels of 200 mg/dL or higher, indicates diabetes. Additionally, an A1c level of 6.5% or greater, reflecting average blood sugar over three months, confirms the diagnosis.
Q3: What is the difference between impaired fasting glucose and diabetes?
Impaired fasting glucose (IFG) occurs when fasting plasma glucose ranges from 100-125 mg/dL, while diabetes is diagnosed at 126 mg/dL or higher. IFG represents an intermediate state indicating increased risk of progression to type 2 diabetes and higher cardiovascular disease risk, but does not yet meet diabetes diagnostic criteria.
Q4: What serious complications can develop from untreated diabetes?
Untreated diabetes can cause severe acute metabolic disturbances like diabetic ketoacidosis and hyperglycemic hyperosmolar state. Chronic complications include microvascular damage causing retinopathy, nephropathy, and neuropathy, plus macrovascular effects including myocardial infarction and stroke. Effective glucose management can prevent, delay, or reduce most of these complications.
Q5: Why is early diabetes screening important for adults?
Early detection enables timely intervention and treatment, delaying or preventing diabetes-related complications. The American Diabetes Association recommends screening adults over 45 years old or those with risk factors including high body mass index, physical inactivity, hypertension, and family history of type 2 diabetes. Many individuals with type 2 diabetes are asymptomatic at diagnosis, making screening crucial.
Q6: What is LADA and how does it differ from typical type 2 diabetes?
Latent autoimmune diabetes of adults (LADA) occurs in individuals with type 2 diabetes phenotype who possess islet cell autoantibodies, indicating autoimmune-mediated beta cell destruction. Unlike typical type 2 diabetes, LADA involves immune system attack on insulin-producing cells, representing a distinct pathophysiological mechanism despite similar clinical presentation.
Q7: How do glucose homeostasis categories help identify diabetes risk?
Glucose homeostasis is categorized by fasting glucose and oral glucose tolerance test results. Normal homeostasis is below 100 mg/dL fasting; impaired fasting glucose ranges 100-125 mg/dL; impaired glucose tolerance shows 140-199 mg/dL at two hours post-glucose challenge. Understanding glucose homeostasis pancreatic islets and insulin secretion mechanisms helps clinicians identify at-risk patients before diabetes develops.